Chronic Kidney Disease Improvement in Research and Treatment Act of 2024

The Chronic Kidney Disease Improvement in Research and Treatment Act of 2024 aims to improve prevention, treatment, and patient outcomes for Medicare beneficiaries with chronic kidney disease or end-stage renal disease. Key provisions include expanding Medicare annual wellness visits to include kidney disease screening (effective 2025), increasing access to kidney disease education benefits, and creating a new payment system to support innovative kidney treatments. The bill also requires a study on kidney disease progression in minority populations, establishes a study to increase kidney transplantation rates, and improves transparency in quality programs for kidney care. Additionally, it expands Medigap coverage options for end-stage renal disease patients (effective 2026), giving beneficiaries more choice in their coverage. These changes directly affect Medicare beneficiaries, healthcare providers, and kidney care facilities.